Role of Glutathione in the Multidrug Resistance in Cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Advances in Cell Biology

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2478/v10052-010-0006-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactive oxygen species and antioxidants in signal transduction and gene expression.

  2009cited by this paper
• Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology.

  2009cited by this paper
• Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.

  2008cited by this paper
• [The different aspects of the biological role of glutathione].

  2007cited by this paper
• Substrate recognition and transport by multidrug resistance protein 1 (ABCC1)

  2006cited by this paper
• Expression of γ-glutamyltransferase in cancer cells and its significance in drug resistance

  2006cited by this paper
• Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.

  2006cited by this paper
• Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance.

  2006cited by this paper
• Role of Intracellular Glutathione in Cell Sensitivity to the Apoptosis Induced by Tumor Necrosis Factor α–Related Apoptosis-Inducing Ligand/Anticancer Drug Combinations

  2005cited by this paper
• Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin.

  2004cited by this paper
• Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas.

  2003cited by this paper
• The MRP family of drug efflux pumps

  2003cited by this paper
• [The role of glutathione and glutathione-related enzymes in antioxidative process].

  2003cited by this paper
• Strategies for reversing drug resistance

  2003cited by this paper
• The role of glutathione-S-transferase in anti-cancer drug resistance

  2003cited by this paper
• Enhanced resistance of HeLa cells to cisplatin by overexpression of γ-glutamyltransferase

  2002cited by this paper
• The medicinal chemistry of multidrug resistance (MDR) reversing drugs.

  2002cited by this paper
• Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state.

  2002cited by this paper
• Extra‐cellular thiol metabolism in clones of human metastatic melanoma with different gamma‐glutamyl transpeptidase expression: Implications for cell response to platinum‐based drugs

  2002cited by this paper
• Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice.

  2002cited by this paper
• Thiols in cellular redox signalling and control.

  2001cited by this paper
• Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.

  2001cited by this paper
• Glutathione conjugation as a bioactivation reaction.

  2000cited by this paper
• The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance.

  2000cited by this paper
• ATP-dependent GSH and glutathione S-conjugate transport in skate liver: role of an Mrp functional homologue.

  2000cited by this paper
• Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2.

  2000cited by this paper
• Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress.

  2000cited by this paper
• Structure-activity studies of verapamil analogs that modulate transport of leukotriene C(4) and reduced glutathione by multidrug resistance protein MRP1.

  2000cited by this paper
• Glutathione, oxidative stress and neurodegeneration.

  2000cited by this paper
• Glutathione conjugation as a bioactivation reaction.

  2000cited by this paper
• The multidrug resistance‐associated protein (MRP) is over‐expressed and functional in rat hepatoma cells

  1999cited by this paper
• Gene expression and thiol redox state.

  1999cited by this paper
• Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response.

  1999cited by this paper
• Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione.

  1999cited by this paper
• Structural, mechanistic and clinical aspects of MRP1.

  1999cited by this paper
• The multidrug resistance protein family.

  1999cited by this paper
• Oxidative stress induced in pathologies: the role of antioxidants.

  1999cited by this paper
• Effects of N-nitrosodimethylamine (NDMA) on the oxidative status of rat liver

  1999cited by this paper
• Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.

  1999cited by this paper
• MRP3, an organic anion transporter able to transport anti-cancer drugs.

  1999cited by this paper
• Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1

  1999cited by this paper
• Regulation of JNK signaling by GSTp

  1999cited by this paper
• Roles of MRP2 and oatp1 in Hepatocellular Export of Reduced Glutathione

  1998cited by this paper
• Multidrug resistance mediated by the ATP‐binding cassette transporter protein MRP

  1998cited by this paper
• Plasma glutathione concentrations in children infected with human immunodeficiency virus.

  1998cited by this paper
• L-S,R-buthionine sulfoximine: historical development and clinical issues.

  1998cited by this paper
• Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.

  1998cited by this paper
• Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.

  1998cited by this paper
• Surface Tension, Glutathione Content and Redox Ratio of the Tracheal Aspirate Fluid of Premature Infants with IRDS

  1998cited by this paper
• Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.

  1997cited by this paper
• Antioxidant and redox regulation of gene transcription

  1996cited by this paper
• Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

  1995cited by this paper
• Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.

  1995cited by this paper
• Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.

  1994cited by this paper
• The consequences of nitrofurantoin-induced oxidative stress in isolated rat hepatocytes: evaluation of pathobiochemical alterations.

  1994cited by this paper
• Increase in gamma-glutamylcysteine synthetase activity as a mechanism for butylated hydroxyanisole-mediated elevation of hepatic glutathione.

  1994cited by this paper
• Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.

  1994cited by this paper
• Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

  1994cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Oxidized redox state of glutathione in the endoplasmic reticulum.

  1992cited by this paper
• Contribution of glutathione and glutathione‐dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines

  1991cited by this paper
• Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones.

  1990cited by this paper
• Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects.

  1988cited by this paper
• Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.

  1987cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Combating chemoresistance in breast cancer: exploring tumour microenvironment, combination therapies and drug repurposing strategies

  2025cites this paper
• Near-infrared light-triggered nano-prodrug for cancer gas therapy

  2021cites this paper
• An ultrasensitive fluorogenic probe for revealing the role of glutathione in chemotherapy resistance† †Electronic supplementary information (ESI) available: Synthesis of probes and their characterization, biological methods, supplementary figures. See DOI: 10.1039/c7sc03338a

  2017cites this paper
• Emerging Roles for SIRT5 in Metabolism and Cancer

  2017cites this paper
• Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin.

  2016cites this paper